Featured Story | Wednesday, June 17, 2020 Top-line results from a U.K. study of a low-cost steroid were enough to persuade the National Health Service to approve it for COVID-19 patients requiring oxygen or ventilation. That OK came just hours after the data reveal—and now, some doctors warn there's not enough evidence that it's really effective in treating the coronavirus. read more |
| |
|---|
|
Top Stories Wednesday, June 17, 2020 The Federation of American Hospitals launched a new initiative to raise awareness about a coming deadline for providers to repay advance Medicare payments. read more Wednesday, June 17, 2020 The FDA revoked its emergency green light for a fingerstick COVID-19 antibody blood test developed by Chembio Diagnostic Systems following new concerns over the test’s accuracy. read more Wednesday, June 17, 2020 On the heels of some big fundraising moves and in the hunt for a COVID-19 vaccine, Novavax is adding some heft to its executive team. Joining the vaccine specialist as chief medical officer is Filip Dubovsky, an AstraZeneca veteran. read more Wednesday, June 17, 2020 CureVac has received regulatory clearance to start a phase 1 trial of its COVID-19 vaccine. The start of the 168-subject study comes days after the German government invested €300 million ($337 million) in CureVac to support its efforts to develop and manufacture a vaccine against the coronavirus. read more Wednesday, June 17, 2020 As it began planning a response to the COVID-19 pandemic, CVS Health established several guiding principles for the work to follow, according to CEO Larry Merlo. read more Wednesday, June 17, 2020 Novavax poached AstraZeneca vet Filip Dubovsky to serve as CMO and lead its COVID-19 vaccine work. Two biotechs touted antibody treatments against the virus, and "Operation Warp Speed" took more heat for its funding of new vaccine technology. Plus, Stéphane Bancel offered some puzzling odds for Moderna's COVID shot. read more Wednesday, June 17, 2020 Follow along with the latest COVID-19 news straight from the Fierce Healthcare team. read more Wednesday, June 17, 2020 Yet another drugmaker is aiming to control the dangerous cytokine storm in COVID-19: Humanigen, a company briefly run by fallen “Pharma Bro” Martin Shkreli. Now it is reporting positive data from the compassionate use of its experimental drug lenzilumab in a small group of patients. read more Wednesday, June 17, 2020 Leaders of major hospital system Tenet shared that its facilities in Arizona are not overwhelmed despite a drastic rise in COVID-19 cases and hospitalizations. read more Wednesday, June 17, 2020 PTC Therapeutics is throwing its hat in the ring for a potential reworked pipeline med against COVID-19. read more Wednesday, June 17, 2020 Sutter Health is asking for a delay in approval of a massive $575 million settlement after the COVID-19 pandemic wreaked havoc on its finances. read more Wednesday, June 17, 2020 Major CRO PRA Health is teaming up with tech giant Microsoft to boost its so-called Health Harmony COVID-19 monitoring program. read more |
|
